<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; situ cancer</title>
	<atom:link href="http://symptomadvice.com/tag/situ-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Nasopharyngeal sarcoma</title>
		<link>http://symptomadvice.com/nasopharyngeal-sarcoma/</link>
		<comments>http://symptomadvice.com/nasopharyngeal-sarcoma/#comments</comments>
		<pubDate>Tue, 21 Dec 2010 01:34:11 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[lung symptoms]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[cancers]]></category>
		<category><![CDATA[completion rate]]></category>
		<category><![CDATA[situ cancer]]></category>
		<category><![CDATA[standard time]]></category>
		<category><![CDATA[target population]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/nasopharyngeal-sarcoma/</guid>
		<description><![CDATA[symptoms of nasopharyngeal carcinoma, nasopharyngeal carcinoma treatment early diagnosis and early treatment of NPC Technical ProposalThe project intends the &#102;&#111;&#117;&#114; cities in Guangdong Province and Guangxi Zhuang Autonomous Region &#116;&#111; carry out Cangwu screening and early detection of nasopharyngeal carcinoma governance. screening targeted &#097;&#116; 30-59 year-old local resident. with head and neck examination and EB [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2010/12/1292895251-64.jpg" style="clear:both;clear:both;margin:0 15px 15px 0;width:500px" />
<p>symptoms of nasopharyngeal carcinoma, nasopharyngeal carcinoma treatment</p>
<p>early diagnosis and early treatment of NPC Technical ProposalThe project intends</p>
<p>the &#102;&#111;&#117;&#114; cities in Guangdong Province and Guangxi Zhuang Autonomous Region &#116;&#111; carry out Cangwu screening and early detection of nasopharyngeal carcinoma governance. screening targeted &#097;&#116; 30-59 year-old local resident. with head and neck examination and EB virus antibody (VCA / IgA) detection &#097;&#115; &#097; screening tool, further positive serology and nasopharyngeal endoscopy &#116;&#111; the diagnosis based &#111;&#110; pathological examination. the discovery of early cancer and cancer patients &#116;&#111; carry out appropriate treatment.</p>
<p>specific number of screening: Screening of &#101;&#097;&#099;&#104; project site not &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 10,000, the number of diagnostic tests &#097;&#116; &#108;&#101;&#097;&#115;&#116; 700 people.</p>
<p>performance indicators requirements: screening task completion rate ? 100%; Compliance ? 70%; early diagnosis rate of ? 50%; cure rate ? 80%; time compliance rate of diagnosis and treatment of ? 95%.</p>
<p>actual task completion rate = Number Screening / Screening number of tasks;</p>
<p>compliance = number of screening the target population of actual / current number of the target population;</p>
<p>early diagnosis rate = (carcinoma in situ I of Cancer II cancers) / (carcinoma in situ cancer);</p>
<p>treatment rate = actual number of patients treated / number of cases should &#098;&#101; treated;</p>
<p>diagnostic standard time compliance rate = actual number of (? 1 biopsy pathology report &#116;&#111; months) / number should &#098;&#101; standard.</p>
<p>aging treatment standards compliance rate = actual number of (? 1 pathology report &#116;&#111; months &#097;&#102;&#116;&#101;&#114; treatment) / number should &#098;&#101; standard.</p>
<p>(a) the establishment of the queue.</p>
<p>population of the project &#105;&#115; based &#111;&#110; the work of early diagnosis and early treatment, require that the project &#119;&#105;&#108;&#108; carry out before specific screening groups and control subjects in order &#116;&#111; evaluate the program. proposed household sector from the local public security organs &#116;&#111; obtain screening population, the total population of the control group and the establishment of &#097; database, &#097;&#108;&#111;&#110;&#103; with carrying out the project covered the counties (districts and townships) all groups The death surveillance. in the &#119;&#104;&#111;&#108;&#101; cause of death based &#111;&#110; monitoring, focusing &#111;&#110; cancer incidence and death registration. cancer incidence and death registration in accordance with the guide the work of Cancer Registration in China, the standards.</p>
<p>( b) the choice of screening people.</p>
<p>cluster sampling method &#116;&#111; determine the higher incidence of NPC town &#111;&#114; village &#097;&#115; &#097; screening population, complete the entire population registered. &#116;&#111; carry out the health of nasopharyngeal carcinoma knowledge, advocacy, awareness and health knowledge of nasopharyngeal carcinoma high-risk groups the participation rate. screening criteria matches the crowd &#116;&#111; participate in screening compliance target of not &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 70% rate of early treatment should &#098;&#101; treated &#110;&#111; &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; the number of 80%.</p>
<p>key target &#102;&#111;&#114; the screening of high incidence of local residents 30-59 years of age (no other serious illness, volunteered &#116;&#111; participate and &#119;&#104;&#111; can accept checks). Based &#111;&#110; previous field studies ,30-59-year-olds &#097;&#098;&#111;&#117;&#116; of the total population of 1 / 3, in accordance with the participation rate &#119;&#097;&#115; 70%, such &#097;&#115; the number of people &#112;&#101;&#114; year &#116;&#111; &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 5,000 people screened, 3-year screening group &#102;&#111;&#114; &#097; total of &#110;&#111; &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 65,000 people.</p>
<p>(c) the choice of control subjects.</p>
<p>control subjects and screening populations &#116;&#111; have &#097; certain geographical buffer &#116;&#111; avoid &#115;&#111;&#109;&#101; of the control group participated in the early diagnosis and early treatment result of the project bias. control regions corresponding &#116;&#111; the tumor incidence and death &#116;&#111; carry out the registration-based monitoring of all causes of death, &#115;&#111; that the final evaluation of the performance of early diagnosis and early treatment. In addition &#097; small sample of selected risk factors in the control group were monitored &#102;&#111;&#114; quality control screening population comparability with the control group.</p>
<p>control subjects &#097; variety of situations (eating habits, socioeconomic status, &#101;&#116;&#099;.) should &#098;&#101; &#097;&#115; consistent with the target population. the control group should carry out baseline survey of screening people &#097;&#116; the &#115;&#097;&#109;&#101; time. control baseline survey of the village population stratified random sampling can &#098;&#101; carried out. sample size of the actual situation according &#116;&#111; the decision of the scene, but &#110;&#111; &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 600 people, &#101;&#097;&#099;&#104; age group (5-year-old age group) not &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 100 people.</p>
<p>Second, the screening flow chart</p>
<p>three screening procedures</p>
<p>(a) informed consent.</p>
<p>screening of all participants people must participate in informed consent procedure. The program consists of &#116;&#119;&#111; &#112;&#097;&#114;&#116;&#115;: the &#102;&#105;&#114;&#115;&#116; call &#116;&#111; participate in the mass screening, focused screening propaganda purpose, significance and participation in screening &#102;&#111;&#114; benefits and possible risks, read the informed consent form, answered the masses problem. and &#116;&#104;&#101;&#110; &#098;&#121; hand &#116;&#111; participate in the mass screening of the relevant description of screening, further &#116;&#111; &#097;&#110;&#115;&#119;&#101;&#114; the &#113;&#117;&#101;&#115;&#116;&#105;&#111;&#110; do not understand. Finally, &#117;&#110;&#100;&#101;&#114; the principle of voluntary informed consent.</p>
<p>(b) of the questionnaire.</p>
<p>signed the informed consent of the people receiving baseline information survey. baseline survey covered health knowledge survey information and Hospital survey of &#116;&#119;&#111; &#112;&#097;&#114;&#116;&#115;, unified &#098;&#121; the prior completion of professional training &#102;&#111;&#114; investigators. all before &#097; formal investigation, should &#098;&#101; based &#111;&#110; local conditions, pre-survey &#116;&#111; become familiar with research project &#116;&#111; understand the investigation process may occur other problems, cancer, early detection and timely treatment &#116;&#111; the model base reflect the Expert Group. Baseline information survey &#119;&#097;&#115; &#116;&#111; evaluate the project performance baseline &#105;&#115; &#105;&#109;&#112;&#111;&#114;&#116;&#097;&#110;&#116; .</p>
<p>health knowledge survey includes &#097; comprehensive knowledge of cancer prevention and treatment of nasopharyngeal carcinoma in &#116;&#119;&#111; &#112;&#097;&#114;&#116;&#115;. baseline survey of knowledge of cancer prevention and control in the early diagnosis and early treatment should &#098;&#101; formally launched before the completion of work in order &#116;&#111; carry out &#097;&#110; &#097;&#099;&#099;&#117;&#114;&#097;&#116;&#101; picture of early diagnosis Early treatment before the knowledge of the local people&#8217;s health situation.</p>
<p>clinical investigation include basic personal information, family history and simple physical examination.</p>
<p>Hospital Survey of the major local hospitals &#116;&#111; collect nasopharyngeal cancer patients admitted &#116;&#111; the basic situation, including the proportion of patients and treatment methods.</p>
<p>basic information over the baseline questionnaire &#102;&#111;&#114; &#101;&#097;&#099;&#104; project, in strict accordance with the investigation and complete coding instructions. &#101;&#118;&#101;&#114;&#121; day the completed questionnaire, requiring 10% of randomly selected &#102;&#111;&#114; review, &#097;&#102;&#116;&#101;&#114; review of the purpose of compliance rate of not &#108;&#101;&#115;&#115; &#116;&#104;&#097;&#110; 90%. Data entry requirements &#116;&#119;&#105;&#099;&#101;, and &#116;&#104;&#101;&#110; &#116;&#111; the original questionnaire &#097;&#115; the standard proofreading &#116;&#119;&#105;&#099;&#101; the data entry, sorting &#105;&#110;&#116;&#111; the final database . database reporting requirements of &#098;&#111;&#116;&#104; time and code documentation submitted &#116;&#111; the field.</p>
<p>(c) clinical examination.</p>
<p>1. medical history inquiry</p>
<p>nasopharyngeal cancer screening check &#119;&#104;&#101;&#110; the &#102;&#105;&#114;&#115;&#116; object &#116;&#111; ask medical history and family history screening, this method &#105;&#115; &#109;&#111;&#115;&#116; convenient, &#105;&#115; also &#118;&#101;&#114;&#121; effective. screening &#115;&#111;&#109;&#101; of the symptoms complained of &#097;&#110; object can provide clinicians with &#105;&#109;&#112;&#111;&#114;&#116;&#097;&#110;&#116; information, &#097;&#108;&#108;&#111;&#119; clinicians &#116;&#111; strengthen vigilance.</p>
<p>2. palpation of cervical lymph node</p>
<p>should &#098;&#101; the object of &#101;&#097;&#099;&#104; screening examination. check should pay attention &#116;&#111; in order &#116;&#111; avoid omissions. generally the order can &#098;&#101; &#097;&#115; follows: ? the group of deep cervical lymph nodes, the chain in &#102;&#114;&#111;&#110;&#116; of the internal jugular vein (deep &#116;&#111; the posterior belly of digastric muscle) &#111;&#114; rear (below the mastoid tip, and before the deep surface of sternocleidomastoid muscle) of the lymph nodes, and deep in the neck, the next group of lymph nodes; ? &#098;&#097;&#099;&#107; of the neck Triangle Area nerve lymph node chain; ? the supraclavicular lymph node chain transverse cervical artery; ? submandibular, submental, preauricular, occipital and other superficial lymph nodes &#097;&#102;&#116;&#101;&#114;. nasopharyngeal carcinoma lymph node metastasis, &#109;&#111;&#115;&#116; often &#111;&#110; the deep cervical the &#102;&#105;&#114;&#115;&#116; group of lymph nodes (deep &#116;&#111; the posterior belly of digastric muscle) &#111;&#114; posterior (in the mastoid tip and the bottom of the deep surface of sternocleidomastoid), part of the &#102;&#105;&#114;&#115;&#116; appeared in the posterior triangle lymph node nerve area. Check these &#112;&#097;&#114;&#116;&#115; of lymph nodes, &#101;&#115;&#112;&#101;&#099;&#105;&#097;&#108;&#108;&#121; &#111;&#110; the deep cervical lymph nodes should &#098;&#101; highly suspected nasopharyngeal carcinoma.</p>
<p>3. &#097; variety of serum EB virus antibodies</p>
<p>EB virus associated with different antibodies EB virus reflects the acute, chronic, persistent infection, convalescence &#111;&#114; &#112;&#097;&#115;&#116; infection status. testing the corresponding antibodies, contribute &#116;&#111; the diagnosis and treatment. The variety of the significance of detection of antigen-antibody reaction in natural populations, nasopharyngeal carcinoma high-risk groups, precancerous lesions and early cancer detection has &#098;&#101;&#101;&#110; verified.</p>
<p>serum EB virus VCA / IgA test, serum EB virus EA / IgA test, serum EB virus EA / IgG were detected &#098;&#121; immunoenzyme method.</p>
<p>criterion test results are &#097;&#115; follows. negative cells: cells are not colored, &#111;&#114; pale brown background color; positive cells: the brown cells in the membrane &#097;&#114;&#111;&#117;&#110;&#100; the color depth.</p>
<p>(1) indirect nasopharyngeal mirror</p>
<p>indirect nasopharyngoscopy tools and operation &#105;&#115; &#114;&#101;&#108;&#097;&#116;&#105;&#118;&#101;&#108;&#121; simple, can peep nasopharyngeal cavity, the diagnosis Early mucosal lesions of nasopharyngeal carcinoma and found significant.</p>
<p>Methods: subjects riding, head slightly &#102;&#111;&#114;&#119;&#097;&#114;&#100;, mouth, nose breathing, the examiner left hand holding &#097; spatula, pressing Sheqian 2 / 3, expanding base of the tongue from the pharyngeal arch, right hand holding the nasopharynx heating without hot mirror, mirror up, &#105;&#110;&#116;&#111; the soft palate and pharyngeal wall &#098;&#101;&#116;&#119;&#101;&#101;&#110; the &#098;&#097;&#099;&#107; and try &#116;&#111; avoid touching the tongue base, pharyngeal arch, pharyngeal wall, &#115;&#111; &#097;&#115; &#116;&#111; avoid gag reflex of inspection. rotating mirror can &#098;&#101; observed in the wall of the structure of the nasopharynx, nasopharyngeal should check the &#116;&#111;&#112; of the order (especially the &#102;&#114;&#111;&#110;&#116; &#116;&#111;&#112; area), &#098;&#111;&#116;&#104; sides of the wall (with particular attention &#116;&#111; check the pharyngeal recess), and the bilateral compared &#116;&#111; observe whether bilateral symmetry nasopharynx, nasal cavity &#105;&#115; narrow. check should pay special attention &#116;&#111; whether the nasopharyngeal mucosa thickening, rough, congestion, bleeding, ulcers, infiltration, the new biology. &#119;&#104;&#101;&#114;&#101; the mucous membrane of isolated nodules &#111;&#114; asymmetry &#117;&#110;&#100;&#101;&#114; the uplift, &#101;&#115;&#112;&#101;&#099;&#105;&#097;&#108;&#108;&#121; in the wall &#111;&#114; place &#111;&#110; the basis of the adenoids, and even more should pay attention &#116;&#111;. In general, &#109;&#111;&#115;&#116; of the subjects in the nasopharynx &#116;&#111; the nasopharynx indirect microscope peep the normal structure of the wall &#111;&#114; abnormal change If the gag reflex sensitivity, can &#098;&#101; 1% -2% of the lidocaine spray 1-3 times &#116;&#111; do the pharyngeal mucosa &#097;&#102;&#116;&#101;&#114; topical anesthesia examination.</p>
<p>(2) nasopharynx fiber mirror</p>
<p>As nasopharyngeal fiber Mirror &#105;&#115; soft, easy &#116;&#111; operate, there are enlarged vision, and &#099;&#111;&#117;&#108;&#100; direct bite taken &#117;&#110;&#100;&#101;&#114; direct vision biopsy suspicious tissue. Therefore, this examination method has &#098;&#101;&#101;&#110; applied &#116;&#111; the screening of nasopharyngeal carcinoma.</p>
<p>ways: &#102;&#105;&#114;&#115;&#116; with 2% of bilateral nasal ephedrine nasal spray &#116;&#111; shrink and shrink small blood vessels, and &#116;&#104;&#101;&#110; with 1% -2% of the lidocaine and inhalation of bilateral nasal spray &#102;&#111;&#114; the surface of the nasopharynx anesthesia, the 2-3, the patient lying &#111;&#110; the examining table, the surgeon &#119;&#104;&#111; left the Department of nasopharyngeal fiber mirror control, right hand holding the &#116;&#111;&#112; of the Ministry of fiber mirror inserts, from the &#115;&#105;&#100;&#101; of the nasal cavity &#116;&#104;&#114;&#111;&#117;&#103;&#104; the nasal passages &#105;&#110;&#116;&#111; the fiber &#117;&#110;&#100;&#101;&#114; the microscope &#116;&#111; the nasopharynx &#098;&#121; adjusting the angle of bending the Department &#116;&#111; observe the entire nasopharynx cavity condition, structure, symmetry, mucous membrane color, with &#111;&#114; without the new biology and new bio-location, size and shape. &#105;&#110;&#116;&#111; the mirror and &#098;&#097;&#099;&#107; mirror in the process, carefully whether bilateral nasal lesions observed suspicious.</p>
<p>5. nasopharyngeal biopsy</p>
<p>nasopharynx &#111;&#114; nasopharyngeal fiber indirect mirror examination revealed suspicious lesions &#111;&#114; nasopharyngeal cancer, are required &#102;&#111;&#114; nasopharyngeal biopsy in order &#116;&#111; identify pathological diagnosis.</p>
<p>four histological types of NPC</p>
<p>(a) of nasopharyngeal precancerous lesions.</p>
<p>nasopharyngeal epithelial precancerous lesion &#105;&#115; moderate &#111;&#114; severe atypia change, mild atypia change can not &#098;&#101; considered precancerous lesions.</p>
<p>(b) of the keratinizing squamous cell carcinoma &#111;&#114; squamous cell carcinoma.</p>
<p>keratinizing squamous cell carcinoma of the nasopharynx can &#098;&#101; divided &#105;&#110;&#116;&#111; well-differentiated, moderately differentiated and poorly differentiated levels.</p>
<p>(c) non- keratinizing carcinoma.</p>
<p>non-keratinizing nasopharyngeal carcinoma can &#098;&#101; divided &#105;&#110;&#116;&#111; differentiated, undifferentiated and mixed type of Sanya. whether differentiated non-keratinizing nasopharyngeal carcinoma &#111;&#114; undifferentiated nasopharyngeal cancer, can lead &#116;&#111; varying amounts of lymphoid cell infiltration in class. cell nucleus can &#098;&#101; detected EBERs. This type of tumor, called the lymphatic epithelial cancer.</p>
<p>1. differentiated non-keratinizing carcinoma</p>
<p>some differentiated non-keratinizing nasopharyngeal carcinoma cells almost fusiform, &#116;&#104;&#101;&#110; can &#098;&#101; called spindle-cell non-keratinizing carcinoma.</p>
<p>2 . non-keratinizing undifferentiated carcinoma &#111;&#114; undifferentiated carcinoma of nasopharyngeal type</p>
<p>classic undifferentiated nasopharyngeal carcinoma, in &#111;&#117;&#114; country has &#098;&#101;&#101;&#110; called the large &#114;&#111;&#117;&#110;&#100; cell carcinoma.</p>
<p>3. Mixed non-keratinizing carcinoma</p>
<p>(d) of nasopharyngeal carcinoma.</p>
<p>1. ordinary adenocarcinoma</p>
<p>cancer can &#098;&#101; divided &#105;&#115; differentiated, moderately differentiated and poorly differentiated levels. &#115;&#111;&#109;&#101;&#116;&#105;&#109;&#101;&#115; visible focal squamous metaplasia lesions may &#098;&#101; referred &#116;&#111; &#097;&#115; focal squamous metaplasia associated with adenocarcinoma. differentiation phase if the cancer &#105;&#115; clear, glandular coexist with squamous metaplasia should &#098;&#101; referred &#116;&#111; &#097;&#115; adenosquamous carcinoma. papillary carcinoma &#105;&#115; &#097; nasopharyngeal cancer &#105;&#115; more common subtypes, &#115;&#111;&#109;&#101; of mucinous adenocarcinoma of the nasopharynx, and its morphology and Results similar rectal adenocarcinoma can &#098;&#101; called intestinal cancer.</p>
<p>2. salivary adenocarcinoma</p>
<p>one of the &#109;&#111;&#115;&#116; common are adenoid cystic carcinoma, &#102;&#111;&#108;&#108;&#111;&#119;&#101;&#100; &#098;&#121; mucus epidermoid tumor.</p>
<p>(e) carcinoma in situ.</p>
<p>five principles of treatment</p>
<p>Radiation therapy &#105;&#115; the preferred cure &#102;&#111;&#114; NPC, in accordance with the hierarchical General principles of treatment, the majority of early cases can &#098;&#101; treated with radiotherapy alone, &#097; small number of the radiosensitivity of tumors and in advanced cases with poor adjuvant chemotherapy &#111;&#114; may &#098;&#101; sensitizing agent, in order &#116;&#111; improve the outcome. &#102;&#111;&#114; &#115;&#111;&#109;&#101; early stage patients, such &#097;&#115; tumor confined &#116;&#111; the cavity, &#097;&#102;&#116;&#101;&#114; nostril in patients with mild involvement, but also external beam brachytherapy, external beam radiotherapy &#116;&#111; reduce the damage.</p>
<p>(a) &#111;&#117;&#116;&#115;&#105;&#100;&#101; the normal nasopharyngeal irradiation.</p>
<p>line with 60Co? &#111;&#114; linear accelerator 6-8MV high-energy X ray; cervical lymph node irradiation &#117;&#115;&#105;&#110;&#103; 60Co? line &#111;&#114; linear accelerator 6-8MV high-energy X ray, and 6-12Mev the electronic line &#111;&#114; 180-210KV deep X line. linear accelerator 6-8MV high-energy X ray , total dose 66-70Gy ,33-35 ,6-7 weeks time. segmentation conventional radiation 5 days &#097; week, 1 time / day, tissue dose (DT) 1.8-2Gy / second, continuous irradiation.</p>
<p>(b) of the endovascular brachytherapy.</p>
<p>intraluminal high dose rate brachytherapy with iridium 192 (192Ir), the effective dose distribution &#119;&#105;&#116;&#104;&#105;&#110; the tumor &#105;&#115; limited &#116;&#111; 1cm, with &#097; range of treatment &#115;&#111;&#109;&#101; limitations, &#119;&#104;&#105;&#099;&#104; can only treat small and superficial tumors, &#097;&#115; &#097; supplement external radiation therapy. clinically often associated with external radiation and &#102;&#111;&#114; the early cases, residual nasopharyngeal carcinoma &#097;&#102;&#116;&#101;&#114; radiotherapy and the treatment of nasopharyngeal recurrence . dose and segmentation: nasopharyngeal lesions &#097;&#102;&#116;&#101;&#114; external beam 60Gy, &#112;&#108;&#117;&#115; brachytherapy 10-25Gy. &#101;&#097;&#099;&#104; 3-5Gy, 2-3 times &#112;&#101;&#114; week.</p>
<p>(c) Intensity Modulated Radiation therapy and stereotactic radiation therapy.</p>
<p>conditional NPC patients can &#099;&#104;&#111;&#111;&#115;&#101; intensity modulated radiation therapy. nasopharyngeal residual lesions &#097;&#102;&#116;&#101;&#114; conventional radiotherapy large, not suitable &#102;&#111;&#114; brachytherapy patients may &#099;&#104;&#111;&#111;&#115;&#101; &#116;&#111; &#098;&#101; fractionated stereotactic radiotherapy.</p>
<p>related diseases: lung cancer liver cancer pancreatic cancer gallbladder bile duct neoplasms melanosis fibroma fibroma multiple sclerosis tuberous sclerosis vertigo United States and Nigeria &#119;&#104;&#097;&#116; &#105;&#115; Seoul&#8217;s disease traditional Chinese medicine powder tumor liver &#119;&#104;&#097;&#116; are the symptoms of lung cancer symptoms of advanced bile duct cancer meningioma reticulocyte pituitary tumors and cerebrovascular brain metastases auditory nerve sheath tumor craniopharyngioma brain tumor nodules of melanoma skin cancer lymphoma, lymphosarcoma, multiple myeloma, malignant lymphoma</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/nasopharyngeal-sarcoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
